Previously it expected its earnings to sit between $100 million and $130 million, but, given its increase in business as COVID-19 cases decline, the company has adjusted its EBITDA to between $130 million and $150 million.
“Our mobility business is bouncing back from Omicron much faster than we expected,” said Dara Khosrowshahi, CEO in the SEC filing. “Whether for travel, commuting, or going out at night, we’re seeing healthy and growing demand across all use cases, highlighting just how eager consumers are to get moving again.”
Uber’s healthcare branch, Uber Health, has also been making moves as of late, continuing the tech transport giant’s move into healthcare. This branch though was not mentioned in the filing.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
